SHARE:  
Join Our Email List
SAVE THE DATE:

ASLAN Pharmaceuticals to Host
Research & Development Day 

Thursday, September 15th | 10:00 AM - 1:30 PM ET

NASDAQ: ASLN

The St. Regis Hotel, New York, NY
Presentations Begin: 10:00 AM 
Panel Lunch Discussion: 12:00-1:30 PM 
ASLAN Pharmaceuticals cordially invites you to their hybrid R&D Day in person at the St. Regis Hotel in New York City and virtually via webcast. 
 
The event will include presentations from management as well as Key Opinion Leaders (KOLs) Peter A. Lio, MD (Northwestern University Feinberg School of Medicine) and Shawn Kwatra, MD (Johns Hopkins University). 
 
ASLAN’s leadership team will discuss their pipeline portfolio led by eblasakimab, a novel, first-in-class monoclonal antibody that targets the IL-13 receptor α1 subunit (IL-13Rα1) for the treatment of atopic dermatitis (AD). New clinical data from eblasakimab’s Phase 1b proof-of-concept study and translational data on the unique mechanism of action will be shared, with an update of latest clinical efforts in AD. Additional details will follow closer to the event.  
 
A live question and answer session will follow the formal presentations.
IMPORTANT INFORMATION
Webcast Registration information 

You are required to register in advance for the webcast portion of this event. For those who are unable to listen at this time, a replay of the call will be available by clicking here.
Q&A information 

If you would like to ask a question during the live Q&A, please submit your request to questions@lifesciadvisors.com. 
250 West 55th Street, Suite 3401 
New York, NY 10019 
Copyright © 2022 LifeSci Advisors, LLC, All rights reserved.
This message contains confidential and proprietary information and is intended only for the individual named. If you are not the named addressee you should not disseminate, distribute or copy this e-mail. Please notify the sender immediately by e-mail if you have received this email by mistake and delete this email from your system. All market prices, data and other information contained in this email are not warranted as to completeness or accuracy and are subject to change without notice. Any comments or statements made herein do not necessarily reflect the views of LifeSci Advisors, LLC, its affiliates, subsidiaries or agents. The message is not intended as an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Before opening any attachments please check them for viruses and defects.